DISK DIFFUSION QUALITY-CONTROL GUIDELINES FOR HAEMOPHILUS SUSCEPTIBILITY TESTS USING CEFDINIR, CI-960, FLEROXACIN, TEMAFLOXACIN, AND TROSPECTOMYCIN

被引：5

作者：

BALE, MJ

JONES, RN

ERWIN, ME

KOONTZ, FP

GERLACH, EH

MURRAY, PR

WASHINGTON, JA

机构：

[1] UNIV IOWA,COLL MED,ANTIINFECT RES CTR,IOWA CITY,IA 52242

[2] UNIV IOWA,COLL MED,CLIN MICROBIOL LABS,IOWA CITY,IA 52242

[3] ST FRANCIS REG MED CTR,WICHITA,KS 67214

[4] WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110

[5] CLEVELAND CLIN EDUC FDN,CLEVELAND,OH 44106

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 1992年 / 30卷 / 03期

关键词：

D O I：

10.1128/JCM.30.3.744-745.1992

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A multilaboratory study to determine disk diffusion quality control ranges for Haemophilus influenzae ATCC 49247 and five investigational drugs was performed. Multiple lots of Haemophilus Test Medium and antibiotic disks were used for replicate testing in conformance with the recommendations of the National Committee for Clinical Laboratory Standards. Quality control disk zone diameter ranges were proposed for cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.

引用

收藏

页码：744 / 745

页数：2

相关论文

共 12 条

[1] MIC QUALITY-CONTROL GUIDELINES FOR HAEMOPHILUS SUSCEPTIBILITY TESTS USING CEFDINIR (FK482), CEFEPIME, CEFETAMET, CEFPIROME, CEFTIBUTEN, FLEROXACIN, TEMAFLOXACIN, CLARITHROMYCIN, RP59500, AND TROSPECTOMYCIN [J].

BALE, MJ ;

JONES, RN ;

ERWIN, ME ;

KOONTZ, FP ;

GERLACH, EH ;

MURRAY, PR ;

WASHINGTON, JA .

JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (01) :225-226

[2] ANTIMICROBIAL ACTIVITY EVALUATIONS OF 2 NEW QUINOLONES, PD127391 (CI-960 AND AM-1091) AND PD131628 [J].

BARRETT, MS ;

JONES, RN ;

ERWIN, ME ;

JOHNSON, DM ;

BRIGGS, BM .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1991, 14 (05) :389-401

[3]

BARRY AL, 1989, ANTIMICROB AGENTS CH, V33, P539

[4]

BARRY AL, 1989, DIAGN MICROBIOL INFE, V12, P13

[5] QUALITY-CONTROL LIMITS FOR DISK DIFFUSION AND BROTH MICRODILUTION SUSCEPTIBILITY TESTS WITH HAEMOPHILUS TEST MEDIUM [J].

DOERN, GV ;

GERLACH, EH ;

JORGENSEN, JH ;

MURRAY, PR ;

THORNSBERRY, C ;

WASHINGTON, JA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1991, 14 (06) :485-493

[6] QUALITY-CONTROL LIMITS FOR AMPICILLIN, CARBENICILLIN, MEZLOCILLIN, AND PIPERACILLIN DISK DIFFUSION SUSCEPTIBILITY TESTS - A COLLABORATIVE STUDY [J].

GAVAN, TL ;

JONES, RN ;

BARRY, AL ;

FUCHS, PC ;

GERLACH, EH ;

MATSEN, JM ;

RELLER, LB ;

THORNSBERRY, C ;

THRUPP, LD .

JOURNAL OF CLINICAL MICROBIOLOGY, 1981, 14 (01) :67-72

[7] COMPARATIVE ANTIBACTERIAL ACTIVITIES OF TEMAFLOXACIN HYDROCHLORIDE (A-62254) AND 2 REFERENCE FLUOROQUINOLONES [J].

HARDY, DJ ;

SWANSON, RN ;

HENSEY, DM ;

RAMER, NR ;

BOWER, RR ;

HANSON, CW ;

CHU, DTW ;

FERNANDES, PB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (11) :1768-1774

[8] INVITRO AND INVIVO ANTIBACTERIAL ACTIVITY OF AM-833, A NEW QUINOLONE DERIVATIVE [J].

HIRAI, K ;

AOYAMA, H ;

HOSAKA, M ;

OOMORI, Y ;

NIWATA, Y ;

SUZUE, S ;

IRIKURA, T .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) :1059-1066

[9] IMPROVED MEDIUM FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING OF HAEMOPHILUS-INFLUENZAE [J].

JORGENSEN, JH ;

REDDING, JS ;

MAHER, LA ;

HOWELL, AW .

JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (11) :2105-2113

[10]

NEU HC, 1989, ANTIMICROB AGENTS CH, V33, P1793